Salesforce Friends ...
Health Care: Drugs
Chelsea Therapeutics International Ltd. (CHTP: NASDAQ)
$1.35 0.00 | 0.00%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -50.45M | -37.33M | -25.77M | -35.09M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | -2.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -200.60K | 2.88M | -2.59M | 7.10M |
| (Decrease) Increase In Other Current Liabilities | 252.36K | 272.39K | 314.82K | 13.00K |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 2.65M | 1.99M | -2.72M | 5.95M |
| Net Cash From Continuing Operations | -48.04M | -32.25M | -30.39M | -22.31M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -48.04M | -32.25M | -30.39M | -22.31M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 4.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 61.11M | 11.45M | 14.58M | 2.61M |
| Purchases of Property, Plant & Equipment | -227.47K | -151.84K | -14.04K | -175.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -65.61M | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -172.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -4.73M | 11.34M | 14.56M | 2.38M |
| Issuance of Debt | 0.00 | 0.00 | 4.19M | 7.28M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 8.48M | 57.68M | 12.40M | 112.00K |
| Repayment of Long-Term Debt | 0.00 | -11.47M | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 37.80M | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 46.28M | 46.21M | 16.59M | 7.39M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -6.49M | 25.30M | 762.10K | -12.54M |
Portfolios with CHTP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserLA
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With 100% ...
- UserLIGDOGS
- UserSharebuilder
Latest CHTP Headlines from TheStreet
- Chelsea Therapeutics' CEO Discusses Completion Of EoR Meeting With FDA For Northera Capsules NDA (Transcript) 05.23.12 | 07:05 am
- Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter From Food And Drug Administration For Northera(TM) (droxidopa) Capsules (Transcript) 03.29.12 | 01:03 pm
- Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest 03.23.12 | 05:03 am
- The Next Big Thing in Biotech: FDA Decisions
03.23.12 | 05:03 am - Biotech Stock Chat: Recap 03.15.12 | 11:03 am
- Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.06.12 | 07:03 pm
- Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript) 02.29.12 | 09:02 pm
- Wednesday's Top 10 Articles, Videos on TheStreet 02.29.12 | 01:02 pm
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Monday's Top 10 Articles, Videos on TheStreet 02.27.12 | 02:02 pm
Press Releases for CHTP
- Faruqi & Faruqi, LLP Notifies Investors Of June 4, 2012 Lead Plaintiff Deadline For The Class Action Filed Against Chelsea Therapeutics International - PR Newswire 05.29.12 | 07:05 pm
- Chelsea Therapeutics International Lead Plaintiff Deadline - June 4, 2012: Levi & Korsinsky Reminds Investors With Losses On Their Investment In Chelsea Therapeutics International Of Class Action And The Lead Plaintiff Deadline - Business Wire 05.29.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - PR Newswire 05.21.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.30.12 | 04:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Chelsea Therapeutics International, Ltd. To Contact The Firm - PR Newswire 04.20.12 | 07:04 pm
- Chelsea Therapeutics International Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Chelsea Therapeutics International, Ltd. - Business Wire 04.11.12 | 10:04 am
- Faruqi & Faruqi, LLP Announces Investigation Of Chelsea Therapeutics International, Ltd. - PR Newswire 04.05.12 | 07:04 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.05.12 | 04:04 pm
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Chelsea Therapeutics International, Ltd. - Business Wire 04.05.12 | 12:04 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Chelsea Therapeutics International, Ltd. - Business Wire 02.21.12 | 08:02 am
Partner Headlines for CHTP
- How To Play Chelsea Therapeutics - Seeking Alpha 03.09.12 | 04:03 pm
- 5 High-Risk, High-Reward Biopharma Stocks - Seeking Alpha 02.14.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- Friday Options Recap - Seeking Alpha 12.23.11 | 03:12 pm
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
- Top 30 Rallying Small Cap Stocks With Significant Institutional Buying - Seeking Alpha 06.29.11 | 09:06 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 6 Cash Rich Biotech Stocks With Catalysts - Seeking Alpha 04.08.11 | 08:04 am
